Blockchain Registration Transaction Record

Silo Pharma Collaborates on Drug-Device Study for PTSD Treatment Delivery

Silo Pharma partners with Resyca BV for drug-device study on PTSD treatment delivery. CEO highlights potential of microchip-enabled nasal spray system. Impacting innovative therapeutic delivery methods for stress-induced psychiatric disorders.

Silo Pharma Collaborates on Drug-Device Study for PTSD Treatment Delivery

This news matters as it showcases Silo Pharma's innovative approach to addressing underserved conditions like PTSD and chronic pain. The collaboration with Resyca BV could potentially lead to a breakthrough in therapeutic delivery methods, impacting patients suffering from stress-induced psychiatric disorders.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x9ad625601de80dc8340f26d49eb73bdb079ecf1eee31639f123e716457b286c7
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintmildU4Mt-73d146f6d1244e1459a33f8e3b582045